ELOXEloxx Pharmaceuticals, Inc.同业对比
Eloxx Pharmaceuticals, Inc. 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELOX本股 | $53M#8 | 3.7x#2 | 1.1x#7 | — | -100.0%#6 | -90.7%#12 | — | -12.9%#4 | — | — | — | — |
| VXRT | $80M#1 | 2.0x#1 | 1.0x#5 | 0.3x#1 | 726.7%#1 | 124.4%#1 | 7.6%#1 | 0.0%#1 | 22.5%#1 | — | -24.0%#4 | — |
| CSBR | $68M#2 | — | 17.5x#11 | 1.1x#2 | 4.4%#3 | -125.0%#13 | -1.9%#2 | -0.0%#2 | — | — | -27.6%#5 | — |
| CRDF | $66M#3 | — | 2.5x#10 | 112.0x#6 | -13.2%#4 | -0.9%#6 | -8256.3%#6 | -0.2%#3 | — | — | -63.0%#8 | — |
| CGTX | $65M#4 | — | 2.0x#9 | — | — | 30.9%#3 | — | -71.1%#8 | — | — | -58.5%#6 | — |
| GRMLW | $57M#5 | — | 1.0x#6 | — | — | -71.6%#11 | — | -18.2%#5 | -14.6%#2 | — | 105.7%#2 | — |
| INKT | $55M#6 | — | — | — | — | -15.9%#8 | — | — | — | — | -23.4%#3 | — |
| BKHAU | $54M#7 | — | — | — | — | -30.6%#10 | — | — | — | — | 136.5%#1 | 94.1%#1 |
| CRBU | $48M#9 | — | 0.5x#3 | 4.3x#4 | 11.7%#2 | 0.7%#5 | -1329.4%#4 | -151.0%#10 | — | — | -81.7%#10 | — |
| KLRS | $48M#10 | — | 0.8x#4 | 288.5x#7 | — | 37.2%#2 | -27970.9%#7 | -75.3%#9 | — | — | — | — |
| LONA | $47M#11 | — | 1.4x#8 | — | — | -9.3%#7 | — | -315.5%#11 | — | — | — | — |
| TIL | $47M#12 | — | 0.4x#2 | — | -100.0%#6 | 3.7%#4 | — | -66.5%#7 | — | — | -60.7%#7 | — |
| IMA | $47M#13 | — | 0.3x#1 | 58.2x#5 | -77.1%#5 | -24.0%#9 | -6056.4%#5 | -31.9%#6 | — | — | — | — |
| PTHS | $42M#14 | — | — | 2.5x#3 | — | -444.6%#14 | -193.1%#3 | — | — | — | -68.2%#9 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议